Poly Medicure Limited Share Price & Analysis

₹1702.50−3.74%Updated 4 Sept 2026, 03:30 pm IST

LTP

₹1702.50−3.74%

Open

₹1760.00

High

₹1766.10

Low

₹1691.40

₹1702.50

52W High

₹2110.00

52W Low

₹1182.00

Volume

172K

Lot Size

Sector

Healthcare

Market Cap

₹17K Cr

Face Value

₹5

Mid CapNIFTY 500Nifty Smallcap 250

Price Chart

Candle

Range

Patterns

Fundamentals

P/E

53.90

Sector P/E

54.70

P/B

4.31

EPS

₹31.75

ROE

9.02%

ROCE

12.50%

D/E Ratio

0.11

Div Yield

0.21%

Book Value

₹306.00

Strengths

Low debt relative to equity (D/E 0.1x)

Concerns

Peer Comparison

Company	CMP	Mkt Cap	P/E	P/B	ROE %	ROCE %	D/E
SUNPHARMA Sun Pharmaceutical Industries Limited	₹1,899	₹4.6L Cr	36.1	5.46	16	20.5	0.07
DIVISLAB Divi's Laboratories Limited	₹9,100	₹2.4L Cr	81.1	14.42	16.5	22	0.01
TORNTPHARM Torrent Pharmaceuticals Limited	₹4,857	₹1.8L Cr	82.8	19.58	27.4	15.2	0.33
APOLLOHOSP Apollo Hospitals Enterprise Limited	₹8,650	₹1.2L Cr	59.1	13.13	21.2	17.4	0.88
CIPLA Cipla Limited	₹1,385	₹1.1L Cr	31.3	3.25	11.6	15.5	0.01
ZYDUSLIFE Zydus Lifesciences Limited	₹1,120	₹1.1L Cr	23	4.16	21.2	21.1	0.38
LAURUSLABS Laurus Labs Limited	₹1,840	₹99K Cr	90.9	18.74	18.3	17.8	0.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

POLYMED · as of Mar 2026

Promoters62.44%

FII11.46%0.87pp

DII11.96%0.30pp

Public14.13%0.56pp

Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	53.17%	53.14%	66.02%	62.56%	62.44%	62.44%
FII	14.10%	12.37%	9.91%	11.88%	12.33%	11.46%
DII	5.46%	7.21%	9.34%	12.33%	11.66%	11.96%
Public	27.28%	27.25%	14.72%	13.23%	13.57%	14.13%

Corporate Events

Dividend - Rs 3.50 Per Share

Record: 28 Aug 2026

Dividend27 Aug 2026

To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters

Results6 Aug 2026

Dividend - Rs 3.50 Per Share

Dividend17 Sept 2025

Annual General Meeting/Dividend - Rs 3 Per Share

Dividend18 Sept 2024

Annual General Meeting/Dividend - Rs 3 Per Share

Dividend20 Sept 2023

Latest News

All news

Poly Medicure to discuss Q1 FY26 financial results

*Poly Medicure to discuss Q1 FY26 financial results* in an upcoming investor and analyst call. The company reported its first-quarter results ending June 30, 2026, offering insights into revenue trends and margins. **Key metrics** from the quarter will be scrutinized for growth trajectory and guidance. Investors await commentary on profitability and market expansion. 📊 *STOCKS:* $POLYMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

NSE Filing5 Aug

Medium Impact

Poly Medicure publishes statutory newspaper notice

*Poly Medicure publishes statutory newspaper notice.* This is a routine regulatory disclosure as part of standard corporate practice. No financial or operational updates were included. Such filings are mandatory under Indian corporate law. 📊 *STOCKS:* $POLYMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling

NSE Filing10 Aug

Low Impact

Poly Medicure faces Delhi HC stamp duty matter

*Poly Medicure faces Delhi HC stamp duty matter*\nPoly Medicure Limited is involved in a case at the Delhi High Court concerning a stamp duty matter. The issue pertains to regulatory compliance and could lead to financial liability depending on the outcome. While not immediately threatening operations, it may affect investor sentiment near-term.\n\n📊 *STOCKS:* POLYMEDIC | 🏢 *SECTOR:* Pharma | #LOWIMPACT #legal

NSE Filing8 Jul

Low Impact

Poly Medicure schedules investor and analyst call

*Poly Medicure schedules investor and analyst call.* The company has announced a scheduled interaction for investors and analysts. Such calls are typically for sharing operational updates or strategic developments. No financial figures or major announcements were disclosed. 📊 *STOCKS:* POLYMEDIC | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorCall

NSE Filing22 Jun

Low Impact

Poly Medicure to host investor meet, no major updates

Poly Medicure announced a schedule for its upcoming Investors/Analysts Meet. The event aims to provide general corporate updates. No significant financial or operational developments were disclosed. *Investors may expect routine disclosures without immediate market-moving triggers.* 📊 *STOCKS:* POLYMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet

NSE Filing10 Jun

Low Impact

Financials

Quarterly Results

Metric	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Revenue	₹535 Cr 8.3%	₹494 Cr 11.3%	₹444 Cr 10.2%	₹403 Cr 8.6%	₹441 Cr 4.0%	₹424 Cr 1.0%	₹420 Cr 9.1%	₹385 Cr
Op. Profit	₹110 Cr 0.9%	₹111 Cr 3.5%	₹115 Cr 8.5%	₹106 Cr 10.9%	₹119 Cr 4.4%	₹114 Cr 0.9%	₹115 Cr 10.6%	₹104 Cr
OPM	21.0% 8.7%	23.0% 11.5%	26.0% 0.0%	26.0% 3.7%	27.0% 0.0%	27.0% 0.0%	27.0% 0.0%	27.0%
Net Profit	₹65 Cr 8.5%	₹71 Cr 22.8%	₹92 Cr 1.1%	₹93 Cr 1.1%	₹92 Cr 8.2%	₹85 Cr 2.3%	₹87 Cr 17.6%	₹74 Cr
EPS (₹)	6.54 6.6%	7 22.7%	9.06 1.4%	9.19 1.4%	9.06 7.7%	8.41 2.5%	8.63 11.9%	7.71

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Revenue	₹1.9K Cr 12.3%	₹1.7K Cr 21.4%	₹1.4K Cr 23.3%	₹1.1K Cr 20.9%	₹922 Cr 17.5%	₹785 Cr 14.3%	₹687 Cr 12.6%	₹610 Cr 17.5%	₹519 Cr 14.3%	₹454 Cr
Expenses	₹1.4K Cr 17.8%	₹1.2K Cr 19.6%	₹1.0K Cr 19.7%	₹847 Cr 19.8%	₹707 Cr 24.3%	₹569 Cr 9.4%	₹520 Cr 8.6%	₹479 Cr 20.7%	₹397 Cr 10.0%	₹361 Cr
Op. Profit	₹446 Cr 2.2%	₹456 Cr 26.3%	₹361 Cr 35.2%	₹267 Cr 24.2%	₹215 Cr 0.5%	₹216 Cr 30.1%	₹166 Cr 26.7%	₹131 Cr 7.4%	₹122 Cr 31.2%	₹93 Cr
OPM	24.0% 11.1%	27.0% 3.8%	26.0% 8.3%	24.0% 4.3%	23.0% 17.9%	28.0% 16.7%	24.0% 9.1%	22.0% 4.3%	23.0% 9.5%	21.0%
Other Income	₹119 Cr 26.6%	₹94 Cr 56.7%	₹60 Cr 57.9%	₹38 Cr 5.0%	₹40 Cr 81.8%	₹22 Cr 4.8%	₹21 Cr 5.0%	₹20 Cr 25.0%	₹16 Cr 14.3%	₹14 Cr
Interest	₹21 Cr 50.0%	₹14 Cr 0.0%	₹14 Cr 27.3%	₹11 Cr 83.3%	₹6 Cr 45.5%	₹11 Cr 45.0%	₹20 Cr 42.9%	₹14 Cr 16.7%	₹12 Cr 50.0%	₹8 Cr
Depreciation	₹116 Cr 39.8%	₹83 Cr 31.7%	₹63 Cr 10.5%	₹57 Cr 5.6%	₹54 Cr 12.5%	₹48 Cr 17.1%	₹41 Cr 10.8%	₹37 Cr 27.6%	₹29 Cr 20.8%	₹24 Cr
PBT	₹427 Cr 5.7%	₹453 Cr 31.7%	₹344 Cr 45.1%	₹237 Cr 21.5%	₹195 Cr 8.3%	₹180 Cr 42.9%	₹126 Cr 26.0%	₹100 Cr 3.1%	₹97 Cr 29.3%	₹75 Cr
Tax %	25.0% 0.0%	25.0% 0.0%	25.0% 0.0%	25.0% 0.0%	25.0% 0.0%	25.0% 4.2%	24.0% 31.4%	35.0% 29.6%	27.0% 0.0%	27.0%
Net Profit	₹321 Cr 5.3%	₹339 Cr 31.4%	₹258 Cr 44.1%	₹179 Cr 21.8%	₹147 Cr 8.1%	₹136 Cr 41.7%	₹96 Cr 47.7%	₹65 Cr 8.5%	₹71 Cr 29.1%	₹55 Cr
EPS (₹)	31.78 4.9%	33.41 24.2%	26.91 44.0%	18.69 22.3%	15.28 7.8%	14.17 30.5%	10.86 46.6%	7.41 7.4%	8 28.0%	6.25
Div Payout	11.0% 10.0%	10.0% 9.1%	11.0% 31.3%	16.0% 0.0%	16.0% 11.1%	18.0% 0.0%	18.0% 33.3%	27.0% 8.0%	25.0% 37.5%	40.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Liabilities
Equity Capital	₹51 Cr 0.0%	₹51 Cr 6.3%	₹48 Cr 0.0%	₹48 Cr 0.0%	₹48 Cr 0.0%	₹48 Cr 9.1%	₹44 Cr 0.0%	₹44 Cr 0.0%	₹44 Cr 0.0%	₹44 Cr
Reserves	₹3.1K Cr 12.5%	₹2.7K Cr 90.9%	₹1.4K Cr 19.1%	₹1.2K Cr 14.8%	₹1.0K Cr 13.3%	₹918 Cr 134.8%	₹391 Cr 16.0%	₹337 Cr 14.6%	₹294 Cr 29.5%	₹227 Cr
Borrowings	₹354 Cr 96.7%	₹180 Cr 3.4%	₹174 Cr 16.8%	₹149 Cr 17.3%	₹127 Cr 7.3%	₹137 Cr 33.8%	₹207 Cr 28.6%	₹161 Cr 21.1%	₹133 Cr 31.7%	₹101 Cr
Other Liabilities	₹401 Cr 63.0%	₹246 Cr 14.4%	₹215 Cr 15.0%	₹187 Cr 14.7%	₹163 Cr 34.7%	₹121 Cr 4.0%	₹126 Cr 12.5%	₹112 Cr 19.1%	₹94 Cr 10.6%	₹85 Cr
Total Liabilities	₹3.9K Cr 21.0%	₹3.2K Cr 71.7%	₹1.9K Cr 17.9%	₹1.6K Cr 14.5%	₹1.4K Cr 12.5%	₹1.2K Cr 59.6%	₹767 Cr 17.3%	₹654 Cr 15.8%	₹565 Cr 23.6%	₹457 Cr
Assets
Fixed Assets	₹1.7K Cr 56.3%	₹1.1K Cr 25.0%	₹867 Cr 36.5%	₹635 Cr 30.1%	₹488 Cr 14.6%	₹426 Cr 17.4%	₹363 Cr 18.6%	₹306 Cr 15.5%	₹265 Cr 28.0%	₹207 Cr
CWIP	₹99 Cr 2.0%	₹101 Cr 32.9%	₹76 Cr 2.6%	₹78 Cr 81.4%	₹43 Cr 104.8%	₹21 Cr 16.0%	₹25 Cr 31.6%	₹19 Cr 5.6%	₹18 Cr 10.0%	₹20 Cr
Investments	₹755 Cr 29.8%	₹1.1K Cr 544.3%	₹167 Cr 32.5%	₹126 Cr 63.6%	₹346 Cr 2.3%	₹354 Cr 1316.0%	₹25 Cr 212.5%	₹8 Cr 52.9%	₹17 Cr 466.7%	₹3 Cr
Other Assets	₹1.3K Cr 41.2%	₹930 Cr 24.3%	₹748 Cr 1.4%	₹738 Cr 47.9%	₹499 Cr 18.2%	₹422 Cr 19.2%	₹354 Cr 10.3%	₹321 Cr 21.6%	₹264 Cr 16.3%	₹227 Cr
Total Assets	₹3.9K Cr 21.0%	₹3.2K Cr 71.7%	₹1.9K Cr 17.9%	₹1.6K Cr 14.5%	₹1.4K Cr 12.5%	₹1.2K Cr 59.6%	₹767 Cr 17.3%	₹654 Cr 15.8%	₹565 Cr 23.6%	₹457 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Operating CF	₹246 Cr 5.6%	₹233 Cr 12.4%	₹266 Cr 39.3%	₹191 Cr 55.3%	₹123 Cr 3.4%	₹119 Cr 9.2%	₹131 Cr 23.6%	₹106 Cr 41.3%	₹75 Cr 33.9%	₹56 Cr
Investing CF	₹-224 Cr 81.1%	₹-1.2K Cr 392.5%	₹-241 Cr 34.6%	₹-179 Cr 110.6%	₹-85 Cr 80.5%	₹-436 Cr 300.0%	₹-109 Cr 7.9%	₹-101 Cr 14.8%	₹-88 Cr 57.1%	₹-56 Cr
Financing CF	₹20 Cr 97.9%	₹951 Cr 4855.0%	₹-20 Cr 53.8%	₹-13 Cr 62.9%	₹-35 Cr 111.0%	₹317 Cr 1609.5%	₹-21 Cr 320.0%	₹-5 Cr 131.3%	₹16 Cr	₹0 Cr
Net Cash Flow	₹43 Cr 1533.3%	₹-3 Cr 160.0%	₹5 Cr 600.0%	₹-1 Cr 133.3%	₹3 Cr	₹0 Cr 100.0%	₹1 Cr 0.0%	₹1 Cr 66.7%	₹3 Cr	₹0 Cr
Free Cash Flow	₹-59 Cr 39.2%	₹-97 Cr 977.8%	₹-9 Cr 81.3%	₹-48 Cr 54.8%	₹-31 Cr 229.2%	₹24 Cr 4.0%	₹25 Cr 19.4%	₹31 Cr 542.9%	₹-7 Cr	₹0 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Debtor Days	103d 35.5%	76d 5.6%	72d 6.5%	77d 6.1%	82d 13.9%	72d 5.9%	68d 11.7%	77d 2.5%	79d 2.6%	77d
Inventory Days	323d 38.6%	233d 13.7%	205d 13.5%	237d 8.7%	218d 0.5%	217d 10.0%	241d 29.6%	186d 15.5%	161d 17.0%	194d
Days Payable	91d 30.0%	70d 21.3%	89d 15.2%	105d 8.7%	115d 3.6%	111d 21.8%	142d 15.4%	123d 28.1%	96d 26.7%	131d
Cash Conv. Cycle	335d 40.2%	239d 27.1%	188d 10.0%	209d 13.0%	185d 3.4%	179d 7.8%	166d 19.4%	139d 3.5%	144d 2.9%	140d
Working Capital Days	105d 40.0%	75d 38.9%	54d 21.7%	69d 14.8%	81d 9.5%	74d 76.2%	42d 25.0%	56d 21.1%	71d 29.1%	55d
ROCE	12.0% 33.3%	18.0% 25.0%	24.0% 33.3%	18.0% 5.9%	17.0% 22.7%	22.0% 12.0%	25.0% 13.6%	22.0% 15.4%	26.0% 8.3%	24.0%

Source: Screener.in · Lower days = better efficiency

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral CIPLACipla LimitedNeutral

Frequently Asked Questions

What is Poly Medicure Limited share price today?

Poly Medicure Limited (POLYMED) is currently trading at ₹1,702.5 on NSE, down 3.74% as of the last market session. Prices update daily after market close on MarketNetra.

Is Poly Medicure Limited available in F&O (Futures & Options)?

Yes, Poly Medicure Limited (POLYMED) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.

What is Poly Medicure Limited 52-week high and low?

Poly Medicure Limited's 52-week high is ₹2,110 and the 52-week low is ₹1,182. The current price of ₹1,702.5 is 19.3% below the 52W high.

What is Poly Medicure Limited P/E ratio?

Poly Medicure Limited's current P/E ratio is 53.9. This indicates the market is paying ₹53.9 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.

How to trade Poly Medicure Limited options?

Poly Medicure Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade POLYMED options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.

Poly Medicure Limited Share Price & Analysis

Price Chart

Fundamentals

Peer Comparison

Shareholding Pattern

Corporate Events

Latest News

Financials

Quarterly Results

Annual Profit & Loss

Balance Sheet

Cash Flow Statement

Key Ratios History

Related Analysis

Same Sector

Frequently Asked Questions